What are the guidelines for managing hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hypertension Management Guidelines

The management of hypertension requires a combination of lifestyle modifications and pharmacological therapy, with a target blood pressure of <130/80 mmHg for most adults to reduce morbidity and mortality from cardiovascular events 1.

Diagnosis and Evaluation

Blood Pressure Measurement

  • Patient should be seated with arm at heart level
  • Use properly calibrated device with appropriate cuff size
  • Take at least two measurements at each visit
  • Consider ambulatory blood pressure monitoring (ABPM) for:
    • Unusual BP variability
    • Resistant hypertension (≥3 drugs)
    • Suspected white coat hypertension
    • Symptoms suggesting hypotension 2

Initial Evaluation

  • Routine investigations for all hypertensive patients:
    • Urine test for blood and protein
    • Blood electrolytes and creatinine
    • Blood glucose
    • Serum total:HDL cholesterol ratio
    • 12-lead ECG 2

Treatment Thresholds

  • Immediate drug treatment for:

    • Sustained systolic BP ≥160 mmHg or diastolic BP ≥100 mmHg 2, 1
    • Patients with diabetes or evidence of organ damage 1
  • Consider drug treatment for:

    • Sustained systolic BP 140-159 mmHg or diastolic BP 90-99 mmHg with:
      • Target organ damage
      • Established cardiovascular disease
      • Diabetes
      • 10-year cardiovascular disease risk ≥20% 2

Blood Pressure Targets

  • General target: <130/80 mmHg for most adults 1
  • Higher risk populations (diabetes, renal impairment, established cardiovascular disease): ≤130/80 mmHg 1
  • Minimum acceptable control (audit standard): <150/90 mmHg 2

Non-Pharmacological Management

All patients with hypertension should receive advice on lifestyle modifications:

  • Weight reduction to achieve ideal body weight
  • Physical activity: Regular dynamic exercise (e.g., brisk walking)
  • Dietary modifications:
    • DASH diet rich in fruits, vegetables, and low-fat dairy products 1, 3
    • Sodium restriction to 5g/day 1
    • Increased consumption of fruits and vegetables 2
    • Reduced intake of saturated fat 2
    • Increased intake of oily fish 2
  • Alcohol limitation: <21 units/week for men, <14 units/week for women 2
  • Smoking cessation 2, 1

These lifestyle modifications can reduce blood pressure significantly and may reduce the need for medication or allow lower doses 4.

Pharmacological Management

First-Line Therapy

  • For most patients without compelling indications:
    • Low-dose thiazide diuretics or β-blockers 2
    • ACE inhibitors, ARBs, or calcium channel blockers 1, 4

Special Populations

  • Patients with diabetes and albuminuria/proteinuria:
    • ACE inhibitors preferred 1
  • Black patients:
    • ARB + dihydropyridine CCB or dihydropyridine CCB + thiazide-like diuretic 1
  • Patients with stage 2 hypertension (≥160/100 mmHg):
    • Consider combination therapy with ACE inhibitor/ARB and calcium channel blocker or diuretic 1

Treatment Escalation

  1. Start with monotherapy for mild hypertension
  2. If BP not controlled, use two-drug combination
  3. If BP still not controlled, progress to three-drug combination: RAS blocker + CCB + thiazide diuretic 1
  4. For resistant hypertension, add spironolactone as fourth-line agent 1

Important Considerations and Cautions

  • Avoid combining ACE inhibitors with ARBs - increases adverse effects without additional benefit 1

  • Monitor for orthostatic hypotension, especially in older patients 1

  • Contraindications:

    • Avoid ACE inhibitors/ARBs in women of childbearing potential (teratogenic) 1
    • Discontinue ACE inhibitors/ARBs when pregnancy is detected 5
  • Follow-up:

    • Within 2-4 weeks after starting or changing medications
    • Check serum creatinine and potassium 7-14 days after initiating ACE inhibitors/ARBs 1

Indications for Specialist Referral

  • Urgent treatment needed:
    • Malignant hypertension
    • Severe hypertension (>220/120 mmHg)
    • Impending complications (TIA, left ventricular failure)
  • Suspected secondary hypertension
  • Resistant hypertension (≥3 drugs)
  • Young age (<30 years needing treatment)
  • Pregnancy 2

Effective implementation of these guidelines requires a systematic approach, patient education, and regular monitoring to ensure optimal blood pressure control and reduction of cardiovascular risk.

References

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.